Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

DYLOJECT

DICLOFENAC SODIUM

Standard Dose
37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DYLOJECT is listed in Drugs@FDA under application 022396 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DICLOFENAC SODIUM Form and strength SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JAVELIN PHARMS INC Submission history Latest submission status date: 2016-05-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview DYLOJECT is listed in Drugs@FDA under application 022396 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DICLOFENAC SODIUM Form and strength SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JAVELIN PHARMS INC Submission history Latest submission status date: 2016-05-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DYLOJECT (DICLOFENAC SODIUM) | Drug Monograph | MedicHelpline